Journal of Vaccines and Immunology Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Ting Wang
    Professor, School of Pharmacy
    Anhui Medical University
    China
    twangcn@hotmail.com
    JVI

    Research Interest: Nanoparticles, liposomes, solid lipid naonparticles, and anhydrous reverse micelles, drug/vaccine carriers, freeze-drying of pharmaceutics, design, carrying out and analysis of in vivo tests, separation and purification of chemicals, extraction and analysis of therapeutic.

    More Info.
    Silvia Della Bella
    Associate Professor in General Pathology and Immunology
    University of Milan
    Italy
    silvia.dellabella@unimi.it
    JVI

    Research Interest: Immunology, chronic viral infections (hepatitis C virus, Kaposi's sarcoma herps virus), dendritic cells, B cells.

    More Info.
    Julie Bouckaert
    Researcher
    Computational Molecular Systems Biology
    Lille University of Science and Technology
    France
    julie.bouckaert@univ-lille1.fr
    JVI

    Research Interest: Structure-to-function relationships of microbial lectins Structural study of multivalent protein-carbohydrate interactions Analysis of differential glycosylation and bacterial infection pathology during metabolic imbalance Structure-based design of anti-bacterial and anti-fungal drugs.

    More Info.
    Hung-Jen Liu
    Distinguished Professor
    National Chung Hsing University
    Taiwan
    hjliu5257@nchu.edu.tw
    JVI

    Research Interest: Virus and host interaction, signal transduction, vaccine development, biotechnology.

    More Info.
    Vincent C Lombardi
    Assistant Professor
    University of Nevada
    USA
    vlombardi@medicine.nevada.edu
    JVI

    Research Interest: Virology/Microbiology, Biochemistry, Clinical Diagnostics, Molecular Biology, Protein Chemistry.

    More Info.
    Aneta Nitsch-Osuch
    Associate Professor
    Department of Family Medicine
    Warsaw Medical University
    Poland
    anitsch@wum.edu.pl
    JVI

    Research Interest: A specialist in pediatrics and epidemiology.

    More Info.
    Farhid Hemmatzadeh
    Senior Lecturer in Virology
    The University of Adelaide
    Australia
    farhid.hemmatzadeh@adelaide.edu.au
    JVI

    Research Interest: Molecular epidemiology, Development of diagnostic tests for viral disease, Cell culture, Bioinformatics.

    More Info.
    Han Zhang
    Emory University
    USA
    han.zhang@emory.edu
    JVI
    More Info.
    Liping Jin
    Department of Obstetrics and Gynecology
    Fudan University Shanghai Medical College
    China
    jinlp01@163.com
    JVI

    Research Interest: The keywords of my research interest: Reproductive immunology, Thymic stromal lymphopoietin, The costimulatory signal, Trophoblast, Gamma-delta T cell, CD4+CD25bright regulatory T cell, Pregnancy, Miscarriage, The maternal-fetal immune.

    More Info.
    Jing Wang
    Associate Professor
    Institute of Oceanology
    China
    jingwang@qdio.ac.cn
    JVI

    Research Interest: The structure of sulfated polysaccharides extracts from seaweeds. The activity of sulfated polysaccharides such as nephrophaty and Parkinsion Disease. The comprehensive utilization of seaweeds especially Saccharina japonica.

    More Info.
    Shih-Jen Liu
    Associate Investigator
    National Health Research Institutes
    Taiwan
    levent@nhri.org.tw
    JVI

    Research Interest: Currently, his studies focus on the two major directions. The first one is to study the innate receptor TLR and NLR ligands as adjuvant for CTL epitope-based vaccines to treat cancer and the adjuvant effect on the modulation of immune responses will be studied.

    More Info.
    Ernesto Oviedo-Ortas
    Clinical Sciences Expert
    Novartis Vaccines and Diagnostics
    Italy
    ernesto.oviedo-orta@novartis.com
    JVI

    Research Interest: Clinical Immunology.

    More Info.
    Chiara Cadeddu
    Institute of Public Health
    Catholic University of Sacred Heart
    Italy
    chiaracadeddu@yahoo.it
    JVI

    Research Interest: Public Health and Health Technology Assessment, particularly for vaccines. 

    More Info.
    Magda M S C Sampaio
    Professor of Pediatrics
    Universidade de Sao Paulo
    Brazil
    magdascs@usp.br
    JVI

    Research Interest: Pediatric Immunology: Primary Immunodeficiencies (particularly their autoimmune manifestations), Early-onset Autoimmunity, Human Thymus, Mother-Infant Immunological Relationships (focusing Placental and Milk Antibody Transfer).

    More Info.
    Salvatore Chirumbolo
    Professor
    Department of Pathology and Diagnostics
    University of Verona
    Italy
    salvatore.chirumbolo@univr.it
    JVI

    Research Interest: Allergy test in clinical diagnosis, Immunotherapy and in vitro cell assay, Anti-inflammatory properties of natural compounds, Allergy and vaccination, Basophil activation tests.

    More Info.
    View more
    mendeley

    Post-vaccinal reactions following vaccination with the COVID-19 vaccine after first and second dose

    DOI Logo 10.17352/jvi.000060

    Published On: March 05, 2024 | Pages: 006 - 010

    Author(s): Velina Stoeva*, Rosen Mihaylov, Blagovesta Pencheva and Antoineta Mihova

    ORCID Logo  0000-0002-6239-4418

    Abstract View Full Article View
    mendeley

    Considerations for improving future pandemic responses

    DOI Logo 10.17352/jvi.000059

    Published On: February 08, 2024 | Pages: 001 - 005

    Author(s): Mikolaj Raszek*, David Cowley and Alberto Rubio-Casillas

    ORCID Logo  0009-0003-5755-3415

    Abstract View Full Article View
    mendeley

    Evaluation of Anti-SARS-CoV-2 IgG antibody response following COVISHEILD vaccination: A comparison between previously infected and non-infected cohorts

    DOI Logo 10.17352/jvi.000058

    Published On: August 19, 2023 | Pages: 030 - 036

    Author(s): Md Shakeel Ahmed*, Md Zakir Hossain, Md Mamunur Rashid, Istiak Ahmad, Md Zahirul Islam, Meherab Hossain and Hasan Rabbi

    ORCID Logo  0000-0002-3405-2146

    Abstract View Full Article View
    mendeley

    Dietary intervention in enhancing immunity of cancer patients

    DOI Logo 10.17352/jvi.000057

    Published On: August 09, 2023 | Pages: 024 - 029

    Author(s): Dietary intervention in enhancing immunity of cancer patients

    ORCID Logo  0000-0001-8856-3681

    Abstract View Full Article View
    mendeley

    Percutaneous Patent Ductus Arteriosus (PDA) closure: When and how to close Coil VS Occluder “step by step” cases report

    DOI Logo 10.17352/jvi.000056

    Published On: March 22, 2023 | Pages: 015 - 023

    Author(s): Nassime Zaoui*, Amina Boukabous, Nabil Irid, Katia Babou and Sabrina Benamara
    Abstract View Full Article View
    mendeley

    Study of adverse events following 2018 sub-national yellow fever vaccination in Ghana

    DOI Logo 10.17352/jvi.000055

    Published On: February 25, 2023 | Pages: 006 - 014

    Author(s): Douglas Adu-Fokuo, Feng Cheng*, Emily Yin and Elizabeth Giwa
    Abstract View Full Article View
    mendeley

    Alopecia areata

    DOI Logo 10.17352/jvi.000054

    Published On: February 21, 2023 | Pages: 001 - 005

    Author(s): Chieh Chen*

    ORCID Logo  0000-0001-5784-9855

    Abstract View Full Article View
    mendeley

    Characterization of enterotoxigenic Escherichia coli heat-labile toxin (LT) double mutant LTA72R/R192G as a Nontoxic and Effective Mucosal Adjuvant

    DOI Logo 10.17352/jvi.000053

    Published On: October 26, 2022 | Pages: 033 - 039

    Author(s): Li Ben-Qiang, Tao Jie, Cheng Jing-Hua, Shi Ying and Liu Hui-li*
    Abstract View Full Article View
    mendeley

    Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report

    DOI Logo 10.17352/jvi.000052

    Published On: August 08, 2022 | Pages: 029 - 032

    Author(s): Šušol Ondrej, Šušolová Barbora and Hájek Roman*
    Abstract View Full Article View
    mendeley

    Adult-onset Still’s disease complicated with macrophage activation syndrome: A case report

    DOI Logo 10.17352/jvi.000051

    Published On: July 23, 2022 | Pages: 023 - 028

    Author(s): MNSK Perera* and A Gunapala
    Abstract View Full Article View    

     

    Indexing/Archiving